Douglas Thom | FinGad - A Finance Community

Douglas Thom

Information Management Consultant

Send a message

http://www.fingad.com/public_profile/TheDuck

Compliment Theduck

Share this Profile

Suggestions Graph

The Wall Street

Displaying 0 of 0 See All

Current Position:	Information Management Consultant
Education:
Friends:	2 Connections
Company:	objectBusiness Inc.
Industry:	Consulting
Groups:
Investment Style:
Favorite Quote:
Languages:

Compliments

"Awesome to have you here! Look forward to your insights. " said Khanan - CEO at FinGad

Contact Douglas Thom

Theduck's Work

Vote

Antigenics Anti-Cancer

Investment Sector: Equities
Submitted 7 months ago by Theduck , Information Management Consultant at objectBusiness Inc.

Hello, all. You may have noticed a small, young company called Antigenics just had two drugs approved (in Russia). They are still working on approval in the U.S.What makes them interesting is that they seem pretty serious about being successful at this. Keep in mind this company is fairly new and, being a medical research company, should have a ... More...

[ 3 Comments | Send To A Friend | Flag Review ]

cancer biomed biology Russia USA United States AGEN Novartis ATRAGEN Aroplatin AG-707 AG-858 heat shock protein Vesanoid tretinoin Hoffman-LaRoche Biotech Add Tag

| khanan and Basik are now Friends! | khanan and jjwalker are now Friends! | khanan and saiecobest are now Friends! | khanan and asadiqbal are now Friends!

Reviews Graph

Portfolios Graph

Suggestions Graph